|
Name of the product: ABINEDOSA 200 (*)
Active ingredient: Gemcitabine 200 mg (as gemcitabine hydrochloride)
Dosage form: lyophilised injection
Name of the product: ABINEDOSA 1000 (*)
Active ingredient: 1000 mg (as gemcitabine hydrochloride)
Dosage form: lyophilised injection
Dispensing requirements: Rx only
Argentine Industry
Composition:
ABINEDOSA 200:
Each glass bottle contains gemcitabine 200 mg (as gemcitabine hydrochloride), mannitol and sodium acetate.
ABINEDOSA 1000:
Each glass bottle contains gemcitabine 1000 mg (as gemcitabine hydrochloride), mannitol and sodium acetate.
Indications:
ABINEDOSA is indicated for the treatment of patients with locally advanced or metastasic non- small cell lung cancer, of patients with locally advanced or metastatic pancreatic cancer, and of patients with 5-FU refractory pancreatic cancer.
Therapeutic action:
Antineoplastic.
Storage:
Keep at temperature between 15º and 30º C, in the marketed packing. Protect from the light incidence.
Marketed presentations:
ABINEDOSA 200:
Packs containing 1 glass bottle.
ABINEDOSA 1000:
Packs containing 1 glass bottle.
Medicinal speciality authorised by the Ministry of Health.
Certificate Nº 48057
Laboratorio DOSA S.A.
Girardot 1369, (C1427AKC) Buenos Aires, Argentine
Pharmaceutical Director: María C. Terzo, Pharmacist
|
